AI assistant
Sending…
EROAD Limited — Director's Dealing 2022
Jun 8, 2022
66188_rns_2022-06-08_ff2a8554-84ad-4393-add1-3bc42c869bb2.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [82 x 22] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| ToNZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EROAD Limited | |
| Date this disclosure made: | 8-Jun-22 | |
| Date of last disclosure: | 6-Dec-21 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | Selwyn Lyle Pellett | |
| Name of listed issuer: | EROAD Limited | |
| Name of related body corporate (if applicable): | Not applicable | |
| Position held in listed issuer: | Executive Director | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
| Class of affected quoted financial products: | Ordinary shares in EROAD Limited | |
| Nature of the affected relevant interest(s): | Registered holder and beneficial | |
| owner | ||
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 9 | |
| Number held in class after acquisition or disposal: | 236,719 | |
| Current registered holder(s): | Selwyn Pellett | |
| Registered holder(s)once transfers are registered: | Selwyn Pellett | |
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) | ||
| Type of affected derivative: | Not applicable | |
| Class of underlying financial products: | Not applicable | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if | ||
| any): | Not applicable | |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable | |
| Maturity date of the derivative (if any): | Not applicable | |
| Expiry date of the derivative(if any): | Not applicable | |
| Theprice specified in the terms of the derivative(if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable under the | ||
| derivative or the value of the derivative is affected by the value of the underlying financial products: | Not applicable | |
| For that derivative,- | ||
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of therelevant interest in the derivative: | Not applicable | |
| Details of transactionsgiving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 11 | |
| Details of transactions requiring disclosure- | ||
| Date of transaction: | 31/05/2022, 3/06/2022, 7/06/2022 | |
| Nature of transaction: | On market purchase of 236,710.46shares | |
| Name of any other party or parties to the transaction (if known): | Not applicable | |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If | ||
| the consideration was not in cash and cannot be readily by converted into a cash value, describe the | ||
| consideration: | $580,740.14 | |
| Number of financial products to which the transaction related: | 236,710 | |
| If the issuer has a financial products trading policy that prohibits directors or senior managers from | ||
| trading during any period without written clearance (a closed period) | ||
| include the following details— | ||
| Whether relevant interests were acquired or disposed of during a closed period: | Not applicable | |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed during theclosed period: | Not applicable | |
| Date of the prior written clearance (if any): | 30-May-22 |
Summary of other relevant interests after acquisition or disposal:
| Class of quoted financial products: | EROAD Limited ordinary shares | |
|---|---|---|
| Nature of relevant interest: | Registered holder and beneficial owner | |
| For that relevant interest,- | ||
| Number held in class: | 1,835,797 | |
| Current registered holder(s): | Selwyn Pellett & Tracey Herman as trustees | |
| of the Selwyn Pellett Family Trust. Selwyn | ||
| Pellett is also a beneficary of the trust. | ||
| For a derivative relevant interest,- | ||
| Type of derivative: | Not appliable | |
| Details of derivative,- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if | ||
| any): | Not applicable | |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable | |
| Maturity date of the derivative (if any): | Not applicable | |
| Expiry date of the derivative (if any): | Not applicable | |
| The price's specified terms (if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable under the | ||
| derivative or the value of the derivative is affected by the value of the underlying financial products: | Not applicable | |
| For that derivative relevant interest,- | ||
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of the | Not applicable | |
| relevant interest in the derivative: |
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
8-Jun-22 8-Jun-22
More from EROAD Limited
Major Shareholding Notification
2026
Jun 8
Director's Dealing
2026
Jun 8
Major Shareholding Notification
2026
May 28
Major Shareholding Notification
2026
May 27
Report Publication Announcement
2026
May 27
Share Issue/Capital Change
2026
May 27
Proxy Solicitation & Information Statement
2026
May 25
Earnings Release
2026
May 24
Report Publication Announcement
2026
May 24
Board/Management Information
2026
May 21